Crossmark

Metastatic renal cell carcinoma patients of T4 stage who are in status of N1 stage or older than 76 years cannot benefit from cytoreductive nephrectomy

Crossref DOI link: https://doi.org/10.1186/s12885-020-07351-w

Published Online: 2020-09-03

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Zhao

Wu, Hongliang

Yang, Tong

Wu, Yaohai

Yu, Nengwang https://orcid.org/0000-0002-9131-8166
Xu, Zhonghua
Funding

Funding for this research was provided by:

the Focused Research and Development Program of Shandong Province (2017GSF18162, 2017GSF18130)

the Natural Science Foundation of Shandong Province (ZR2018MH024)
License Information

Text and Data Mining valid from 2020-09-03

Version of Record valid from 2020-09-03
More Information

Article History

Received: 15 March 2020

Accepted: 26 August 2020

First Online: 3 September 2020

Ethics approval and consent to participate

: We obtained the permission to access the SEER database with the ID number 10616-Nov2018 via Internet access method. Ethical approval was waived by the local ethics committee, as SEER data is publicly available, de-identified.

: Not applicable.

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below